Wellness & Lifestyle

Ginkgo Bioworks develops autonomous laboratory solutions for biotechnology, empowering scientists to program biology and significantly accelerate research and development. Their offerings include building autonomous labs with hardware, software, and support, as well as cloud lab services where users can run experiments virtually on Ginkgo's Boston-based autonomous lab. The platform aims to shift the focus of scientists from manual benchwork to insight, creativity, and judgment by automating lab processes. Key services include AI services, antibody developability, perturbation response profiling, small molecule developability, and specialized screening. Ginkgo also provides biosecurity solutions through its Canopy and Horizon platforms.

Cellarity is at the forefront of drug discovery, leveraging a multi-omics, AI-powered platform to gain critical insights into cellular dysfunction. Unlike traditional methods limited by human bias, Cellarity's approach maps complex cellular interactions to reveal new biological pathways. This enables the regulation of genetic "switches" to restore proper cell function, leading to the development of "Cell State-Correcting" therapeutics. The platform aims to solve complex diseases by designing medicines that target dynamic cell states, offering a game-changing approach for conditions previously out of reach.

Great Bay Bio (GBB) is a biotech company headquartered in HKSTP, specializing in accelerating drug development through cutting-edge technologies like AI, big data mining, and automation. The company provides a suite of products and services, including AI-enabled CMC, Site-Specific Integration Cell Line Development, Antibody Drug Discovery and Optimization, CHO Cell Culture Media, and Biologics. GBB's intelligent platforms, AlfaDAX, AlfaCell, and AlfaMedX, are designed to transform conventional drug development by significantly reducing timelines and enhancing success rates, offering solutions from molecule design to cell culture media development.

BioBox is the Decision Operating System for AI-driven drug discovery, designed to help biopharma teams manage, integrate, and analyze massive, often siloed, datasets. It enables the creation of custom knowledge graphs that weave together scientific data and encode scientific reasoning, powering AI scientists. Unlike black-box vendors, BioBox ensures proprietary insights remain sovereign, allowing teams to build and evolve their own graphs and models. The platform supports end-to-end integration from public databases to proprietary experiments, bridging discovery to development. Key features include custom knowledge graphs, graph models for AI, an AI research assistant, and real-time multi-omic reports, all designed to accelerate innovation and improve decision-making in drug discovery.

DataForge is a powerful synthetic data generator designed to create realistic test data quickly and efficiently. It supports a wide range of data types, with over 50 general field types and 28 specialized healthcare fields, making it suitable for diverse applications. The tool provides 15 pre-built scenarios to streamline data generation and allows users to export their synthetic data in multiple formats, including JSON, CSV, SQL, and XML. DataForge is HIPAA-safe, ensuring compliance for sensitive healthcare data, and is completely free to use, making it an accessible solution for developers and data professionals.

AMPLY Discovery is at the forefront of pharmaceutical innovation, utilizing a unique blend of AI and evolutionary principles to unearth novel medicines. The platform addresses critical global health challenges such as cancer and drug-resistant infections by accelerating the drug discovery process, which is traditionally costly and slow. AMPLY's technology digitizes biological diversity through next-gen sequencing, creating a vast array of potential solutions in a virtual environment. These digital discoveries are then bio-printed into tangible molecules for rigorous real-world testing in hospital labs, ensuring their efficacy against actual diseases. This approach aims to democratize drug discovery, making it accessible beyond large biopharma companies and targeting a wider range of diseases.

Unlearn.AI revolutionizes clinical development by leveraging AI and digital twins of patients. The platform offers solutions across the entire trial lifecycle, from planning with TrialPioneer, Scout, Hindsight, and SimLab, to continuous monitoring with Anomaly Detection & Clinical Data Surveillance, and advanced analysis using digital twins. These AI-generated forecasts of control outcomes reduce variability and improve the ability to detect treatment effects, supporting smaller sample sizes and increased power. The methodology is qualified by the EMA and aligned with FDA guidance, leading to clearer go/no-go decisions and measurable reductions in trial size, cost, and time to readout. Unlearn.AI is trusted by leading sponsors in neuroscience, immunology, and metabolic disease.

Telegram is a cloud-based mobile and desktop messaging application renowned for its emphasis on security and speed. It allows users to send messages, photos, videos, and files of any type, supporting groups of up to 200,000 members and channels for unlimited audiences. Key features include heavily encrypted messages that can self-destruct, seamless syncing across multiple devices, and an open API for developers. The platform also offers end-to-end encrypted voice and video calls, as well as voice chats in groups. Recent updates include an AI Editor for text translation and transformation, and enhanced polling features. Telegram is free, with no ads or subscription fees, and provides robust privacy settings and device-specific Secret Chats.

igv.js is an embeddable interactive genome visualization component developed by the Integrative Genomics Viewer (IGV) team. It provides a robust solution for integrating genomic data visualization directly into web applications. The component is designed to be lightweight, consisting of a single JavaScript file with no external dependencies, making it easy to install and use. Developers can quickly set up an IGV browser by supplying a container div and an initial configuration, defining the reference genome, tracks, and other state. It supports various genomic data formats and offers comprehensive documentation for its API, enabling extensive customization and control over the visualization experience. The tool is ideal for researchers and developers working with genomic data who need to display and interact with this information in a web-based environment.

DiffDock Web is a specialized tool designed for predicting the binding interactions between proteins and ligands. It allows users to upload a PDB file or enter a PDB code for the protein, and provide a SMILES string or upload a mol2/sdf file for the ligand. The application then processes this information to predict the binding structure. This tool is particularly useful for researchers and professionals in the pharmaceutical and biotechnology fields who need to understand molecular interactions for drug discovery and development. The platform aims to simplify the complex process of molecular docking by providing an accessible web interface.

BIOS is an AI Scientist specifically engineered for biological data analysis. This tool has achieved recognition, ranking #1 on BixBench, a benchmark for biological AI. It supports flexible workflows, allowing for human-in-the-loop checkpoints to ensure oversight and control, alongside a fully autonomous operational mode. The system leverages specialized AI agents, each designed for distinct tasks such as orchestration, comprehensive literature review, in-depth data analysis, and advanced novelty detection within biological datasets. A free tier is available, with academic users benefiting from full, complimentary access using their .edu email addresses.

Generating molecular graphs by WGAN-GP is an AI tool hosted on Hugging Face Spaces, designed to create molecular graphs. The tool leverages a WGAN-GP (Wasserstein Generative Adversarial Network with Gradient Penalty) model for its generative capabilities. While the concept aims to assist in the design of new molecules, potentially benefiting chemists and materials scientists, the current live website indicates a runtime error, preventing its functionality. The error message suggests an issue with loading the Keras model, specifically regarding unsupported file formats in Keras 3. This indicates a technical challenge that needs resolution for the tool to become operational.

EvoDiff - Protein Generation is a powerful AI tool developed by Microsoft Research, available on Hugging Face, designed for generating protein sequences. Users can leverage this tool for both unconditional protein sequence generation or conditional generation based on a provided Multiple Sequence Alignment (MSA) file. This flexibility allows for diverse applications in protein design and research. The platform enables users to specify the desired sequence length and select from various model types to tailor the output to their specific needs, making it a valuable asset for researchers and data scientists in the biotech and pharmaceutical domains. It simplifies the process of creating novel protein sequences, aiding in drug discovery, enzyme engineering, and fundamental biological studies.

The Integrative Genomics Viewer (IGV) is a powerful, open-source desktop application designed for the visualization of genomics data and annotations. It offers fast, efficient, and scalable performance, making it suitable for researchers working with large datasets. IGV supports various data types and allows users to explore genomic information on Mac, Windows, and Linux operating systems. Developers interested in contributing to the project can find detailed instructions for building and running the application, which requires Java 21. The tool also supports loading public data files hosted in Amazon S3 buckets using HTTPS endpoints and authenticated access with s3:// URLs, including OAuth access with Cognito.

Sieve Health is a B2B SaaS platform designed to automate and streamline clinical trial recruitment. It utilizes advanced AI technologies, including medical Natural Language Processing (NLP) and Machine Learning (ML), to improve operational efficiencies for various clinical research stakeholders. The platform's primary goal is to significantly reduce the administrative burden associated with trial matching and patient enrollments. Sieve Health provides automated solutions for clinical trial matching and comprehensive recruitment management, aiming to make the process faster and more efficient.

Deep 6 AI is an artificial intelligence platform designed to enhance and expedite clinical trial enrollment. It utilizes advanced AI and natural language processing (NLP) capabilities to analyze both structured and unstructured patient data. By mining this comprehensive data, the platform can quickly identify patients who meet the specific criteria for clinical trials. This process dramatically reduces the time required to find suitable candidates, transforming a months-long task into a matter of minutes. Deep 6 AI serves a critical role for health systems, pharmaceutical companies, and Contract Research Organizations (CROs) in streamlining their clinical research efforts.

Kode Chemoinformatics offers an AI-powered service specifically designed for the chemical and pharmaceutical sectors. The platform provides comprehensive solutions for managing and analyzing chemical data, utilizing advanced chemometric instruments and machine learning techniques. Key capabilities include Quantitative Structure-Activity Relationship (QSAR) and Quantitative Structure-Property Relationship (QSPR) modeling. This technology supports critical applications such as drug design and ecotoxicological screening, aiming to streamline research and development processes in these industries.

Axom Solutions specializes in AI-powered automation tailored for the pharmaceutical manufacturing industry. Their system integrates robotics, advanced camera systems, and artificial intelligence to perform critical tasks such as visual inspection and counting. It is designed to ensure full batch reconciliation and accurately detect defects on pharmaceutical products like vials and syringes. Axom's solutions prioritize precision and compliance, addressing the stringent requirements of pharmaceutical production environments.

Massive Bio is a health-tech company dedicated to improving cancer treatment outcomes by utilizing artificial intelligence. The platform intelligently matches cancer patients to relevant clinical trials, streamlining a critical and often complex process. Operating internationally, Massive Bio collaborates with pharmaceutical companies and healthcare institutions to expand access to cutting-edge treatments. Its core mission is to significantly accelerate the enrollment process for oncology trials and to minimize patient dropout rates, thereby advancing cancer research and patient care.

Neuroute is an AI-powered platform designed to optimize clinical trial operations. It focuses on accelerating key stages such as patient recruitment and trial monitoring, while also providing predictive analytics capabilities. The platform aims to streamline the entire clinical trial process, from the initial site selection phase through to making data-driven decisions. Neuroute can generate tailored clinical trial designs and operational plans, enhancing efficiency and effectiveness in research.

PharmCADD is a platform specifically designed to expedite the drug discovery process. It leverages a combination of artificial intelligence, molecular dynamics, and quantum calculations to achieve this goal. A key advantage of PharmCADD is its ability to allow users to design and discover drugs without the need for their own high-performance computing infrastructure. The platform integrates both data-derived and physics-based technologies, aiming to deliver drug discovery solutions that are both faster and more accurate than traditional methods.

NEC OncoImmunity AS is a biotech company leveraging artificial intelligence to develop machine-learning software. This software is designed to predict immunogenic antigens, playing a crucial role in the fields of personalized cancer immunotherapy and infectious disease vaccines. Key applications include facilitating patient selection for cancer immunotherapy treatments and identifying specific neoantigen targets for the development of personalized cancer vaccines and cell therapies. The company's technology aims to advance precision medicine in oncology and infectious disease prevention.

neurons.bio is an autonomous AI platform specifically developed to enhance and speed up life science research and drug discovery. The platform's core function is to streamline the complex and often lengthy process of identifying and developing new pharmaceutical drugs. By leveraging artificial intelligence, neurons.bio seeks to provide researchers and organizations with tools that can expedite their work, ultimately bringing new treatments to market faster.

KIWI-biolab specializes in leveraging artificial intelligence and machine learning techniques within the field of bioprocess engineering. The primary goal is to automate the complex process of data analysis related to microorganisms, thereby enabling computational systems to effectively plan and optimize experimental procedures. This focus on automation is driven by a long-term vision to enhance efficiency and sustainability in biotechnology production, streamlining research and development efforts in the biological sciences.